SECsense Logo

Arcus Biosciences, Inc. 8-K Report: Key Updates for Investors (Feb 15, 2025)

$RCUS
Form 8-K
Filed on: 2025-02-18
Source
Arcus Biosciences, Inc. 8-K Report: Key Updates for Investors (Feb 15, 2025)

Based on the provided section of the financial report, here are the key insights and important information extracted:

  1. Company Information:
  • Name: Arcus Biosciences, Inc.
  • Incorporation: Delaware (DE)
  • CIK: 0001724521
  • SEC File Number: 001-38419
  • EIN: 47-3898435
  • Address: 3928 Point Eden Way, Hayward, CA 94545
  • Phone Number: (510) 694-6200
  1. Report Type:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  1. Date of Filing:
  • Filing Date: February 15, 2025
  1. Stock Information:
  • Common Stock: Par Value $0.0001 per share
  • Ticker Symbol: RCUS
  • Exchange: NYSE (New York Stock Exchange)
  1. Context and Time Frame:
  • Period of Report: The report covers the date of February 15, 2025.

This information serves as a summary of the corporate identity, regulatory filing type, and pertinent details regarding the company's stock, which are crucial for investors and analysts assessing the company's compliance and market presence.